Shari A. Pilon
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
-
- CAR-T cell therapy research
Papers in
- Oncology 6
- HER2/EGFR in Cancer Research 3
- CAR-T cell therapy research 2
- Peptidase Inhibition and Analysis 1
-
- Glycosylation and Glycoproteins Research 2
- Polyamine Metabolism and Applications 1
- Microbial Metabolic Engineering and Bioproduction 1
- Co-authors
- Wei‐Zen Wei (6 shared papers)Marie P. Piechocki (5 shared papers)Marten Veenhuis (1 shared paper)Johannes P. van Dijken (1 shared paper)W. Harder (1 shared paper)Ye-Shih Ho (1 shared paper)
- Journals
- The Journal of Immunology (4 papers)Archives of Microbiology (1 paper)Cellular Immunology (1 paper)Journal of Immunological Methods (1 paper)
- Partner nations
- United StatesFranceNetherlands
In The Last Decade
Shari A. Pilon
7 papers receiving 405 citations
Peers
Comparison fields: 5 of 58
- Immunology 238
- Oncology 164
- Radiology, Nuclear Medicine and Imaging 131
- Molecular Biology 206
- Genetics 53
Countries citing papers authored by Shari A. Pilon
This map shows the geographic impact of Shari A. Pilon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shari A. Pilon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shari A. Pilon more than expected).
Fields of papers citing papers by Shari A. Pilon
This network shows the impact of papers produced by Shari A. Pilon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shari A. Pilon. The network helps show where Shari A. Pilon may publish in the future.
Co-authors
The 6 scholars most cited alongside Shari A. Pilon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1978 | 111 | |
| 2 | 2003 | 95 | |
| 3 | 2001 | 62 | |
| 4 | 2001 | 61 | |
| 5 | 2003 | 38 | |
| 6 | 2002 | 35 | |
| 7 | 2001 | 15 |
About Shari A. Pilon
Shari A. Pilon is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology and Infectious Diseases, having authored 7 papers that have together received 417 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (4 papers), HER2/EGFR in Cancer Research (3 papers), CAR-T cell therapy research (2 papers), Glycosylation and Glycoproteins Research (2 papers), Peptidase Inhibition and Analysis (1 paper), Polyamine Metabolism and Applications (1 paper) and Microbial Metabolic Engineering and Bioproduction (1 paper). The work is most often cited by research in Immunology (238 citations), Oncology (164 citations), Radiology, Nuclear Medicine and Imaging (131 citations), Molecular Biology (206 citations) and Genetics (53 citations). Shari A. Pilon has collaborated with scholars based in United States, France and Netherlands. Frequent co-authors include Wei‐Zen Wei, Marie P. Piechocki, Marten Veenhuis, Johannes P. van Dijken, W. Harder and Ye-Shih Ho. Their work appears in journals such as The Journal of Immunology, Archives of Microbiology, Cellular Immunology and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.